Topic
The completion of clinical document authoring is not the end of the road, but rather the beginning of the lifecycle of these documents. Their journey includes many additional…
CANTON, Mich. and PITTSBURGH (August 2, 2025) – TrialAssure, a global leader in AI-enabled, human-driven solutions for the pharmaceutical industry and beyond, announced today that Zach Weingarden, MS,…
Teams in medical writing are being pulled in every direction. Internal experts see how much pressure that they are under to move faster, improve quality, and manage rising…
In many industries, Design for Quality (DfQ) has long been a guiding framework. It teaches us to build quality into the process rather than inspecting for it later.…
Anonymization plays a critical role in clinical trial transparency and data sharing in general, but it is often thought of too late in the process. When anonymization planning…
DIA Europe 2025 in Basel brought together global leaders, innovators, and regulatory experts from across the life sciences community. The event offered valuable opportunities to exchange ideas, explore…
AI continues to gain momentum across the life sciences industry, promising to reshape medical writing and regulatory processes by improving speed, consistency, and efficiency. But for many organizations,…
The European Medicines Agency (EMA) has introduced significant updates to its transparency rules, requiring sponsors and CROs to rethink how they manage clinical trial disclosures. These changes, which…
As part of our Innovation Insights webinar series, TrialAssure is pleased to announce it latest addition with Empowering Medical Writers: GenAI for Automated Tables, Listings, and Figures (TLFs)…
The Current State of Medical Writing Medical writing departments face unprecedented pressure to increase output while maintaining quality and compliance. Empowering medical writers is crucial, as recent RAPS…
